Brain Natriuretic Peptide Normal Levels: 2006 Multi-Industry Data on Diagnostic Assays, Market Growth, and Peptide Product Selection Guide
Abstract: This 2006 multi-industry analysis establishes normal brain natriuretic peptide (BNP) levels (<100 pg/mL) as a diagnostic benchmark, reviewing assay technologies (immunoassay vs. point-of-care) and market growth driven by heart failure prevalence. Peptide product selection criteria include purity (>95%), stability, and regulatory certifications (FDA, CE). Leading brands (Roche, Abbott, Siemens) are compared on sensitivity, specificity, and cost. Logistics require cold-chain compliance (-20°C). The peptide industry shows 8% CAGR, with recombinant BNP dominating over synthetic variants. Key selection tips: verify lot-specific certificates of analysis (CoA) and supplier GMP audits.